X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (53) 53
index medicus (43) 43
cancer (38) 38
female (36) 36
oncology (36) 36
male (34) 34
colorectal cancer (32) 32
middle aged (29) 29
aged (25) 25
chemotherapy (25) 25
colorectal neoplasms - genetics (23) 23
life sciences (23) 23
mutation (20) 20
cetuximab (19) 19
colorectal neoplasms - drug therapy (19) 19
gastroenterology & hepatology (19) 19
prognosis (16) 16
[ sdv.can ] life sciences [q-bio]/cancer (15) 15
adult (15) 15
colorectal neoplasms - pathology (15) 15
metastasis (15) 15
retrospective studies (15) 15
[sdv.can]life sciences [q-bio]/cancer (12) 12
care and treatment (12) 12
survival (12) 12
treatment outcome (11) 11
aged, 80 and over (10) 10
fluorouracil (10) 10
gastroenterology and hepatology (10) 10
health aspects (10) 10
proto-oncogene proteins - genetics (10) 10
analysis (9) 9
antibodies, monoclonal - therapeutic use (9) 9
antibodies, monoclonal, humanized (9) 9
antineoplastic agents - therapeutic use (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
proto-oncogene proteins p21 (9) 9
ras proteins - genetics (9) 9
receptor, epidermal growth factor - antagonists & inhibitors (9) 9
research (9) 9
tumors (9) 9
genetics (8) 8
human health and pathology (8) 8
medicine & public health (8) 8
camptothecin - analogs & derivatives (7) 7
diagnosis (7) 7
disease-free survival (7) 7
mutation - genetics (7) 7
oxaliplatin (7) 7
risk factors (7) 7
signal transduction (7) 7
animals (6) 6
bevacizumab (6) 6
cancer research (6) 6
colorectal neoplasms - diagnosis (6) 6
colorectal neoplasms - mortality (6) 6
egfr (6) 6
hépatology and gastroenterology (6) 6
leucovorin (6) 6
microsatellite instability (6) 6
neoplasm metastasis (6) 6
receptor, epidermal growth factor - genetics (6) 6
surgery (6) 6
1st-line treatment (5) 5
carcinoma (5) 5
cisplatin (5) 5
digestive system diseases (5) 5
drug therapy (5) 5
epidermal growth factor (5) 5
fluorouracil - administration & dosage (5) 5
france (5) 5
gene expression (5) 5
genes, ras (5) 5
genetic aspects (5) 5
growth-factor receptor (5) 5
kaplan-meier estimate (5) 5
kras (5) 5
neoplasm staging (5) 5
phase-ii (5) 5
phosphatidylinositol 3-kinases - genetics (5) 5
proportional hazards models (5) 5
research article (5) 5
squamous cell carcinoma (5) 5
squamous-cell carcinoma (5) 5
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (4) 4
antibodies (4) 4
camptothecin - therapeutic use (4) 4
class i phosphatidylinositol 3-kinases (4) 4
combination (4) 4
disease progression (4) 4
drug resistance, neoplasm (4) 4
expression (4) 4
fluorouracil - therapeutic use (4) 4
france - epidemiology (4) 4
gene amplification (4) 4
gene copy number (4) 4
genotype (4) 4
leucovorin - administration & dosage (4) 4
medical prognosis (4) 4
mortality (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2008, Volume 26, Issue 3, pp. 374 - 379
Journal Article
Hepato-Gastro and Oncologie Digestive, ISSN 2115-3310, 10/2016, Volume 23, pp. 4 - 6
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2018, Volume 119, Issue 3, pp. 1 - 387
Supplementary Table 1 and the Supplementary Figure legends were not included when this manuscript was first published. The files are now available here. 
Proteins | Biomarkers | Bioindicators | Epidermal growth factor receptors | Colorectal carcinoma | Metastases
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 2017, Volume 117, Issue 12, pp. 1819 - 1827
Background: Metastatic colorectal cancer (mCRC) patients with mutant KRAS or NRAS are ineligible for anti-epidermal growth factor receptor (anti-EGFR) therapy,... 
Cell signalling | Resistance | PI3K | Colorectal cancer | Biomarkers | RPPA | EGFR | colorectal cancer | METAANALYSIS | MECHANISM | PRIMARY TUMOR | biomarkers | resistance | PANITUMUMAB | CETUXIMAB | COLON-CANCER CELLS | BENEFIT | ONCOLOGY | cell signalling | GENE-EXPRESSION | MONOCLONAL-ANTIBODIES | Leucovorin - administration & dosage | Phosphorylation | Receptor, ErbB-3 - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Class I Phosphatidylinositol 3-Kinases - genetics | Colorectal Neoplasms - genetics | Epigenesis, Genetic | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Male | Response Evaluation Criteria in Solid Tumors | MAP Kinase Signaling System | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Biomarkers, Tumor - metabolism | Camptothecin - administration & dosage | Female | Retrospective Studies | Wnt Signaling Pathway | Camptothecin - analogs & derivatives | Carcinoma - secondary | Carcinoma - drug therapy | Drug Resistance, Neoplasm - genetics | Antibodies, Monoclonal - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Carcinoma - genetics | Cetuximab - administration & dosage | Mutation | Colorectal Neoplasms - pathology | Genes, ras | Therapy | Wnt protein | Epidermal growth factor receptors | Colorectal carcinoma | MAP kinase | Ras protein | Metastasis | Patients | ErbB-2 protein | K-Ras protein | 1-Phosphatidylinositol 3-kinase | Metastases | Proteins | Signal transduction | Signaling | Protein arrays | Epidermal growth factor | Pathways | Bioindicators | Cancer | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Biochemistry, Molecular Biology | Genomics | Molecular Diagnostics
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2016, Volume 114, Issue 12, pp. 1387 - 1394
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 06/2009, Volume 6, Issue 6, pp. 306 - 307
On the basis of the results of KRAS analysis from the CO.17 randomized, controlled, phase III study by Karapetis et al., KRAS mutations have emerged as a valid... 
ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Colorectal Neoplasms - drug therapy | Colorectal Neoplasms - genetics | Humans | Drug Resistance, Neoplasm | Proto-Oncogene Proteins - genetics | Antineoplastic Agents - therapeutic use | Mutation - genetics | Colorectal Neoplasms - diagnosis
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 9, pp. 2126 - 2133
Journal Article
European Journal of Cancer, ISSN 0959-8049, 04/2019, Volume 111, pp. 94 - 106
Journal Article
European Journal of Cancer Prevention, ISSN 0959-8278, 01/2019, Volume 28, Issue 1, p. 27–32
International studies have shown a significant reduction in colorectal cancer (CRC) mortality following the implementation of organized screening programs,... 
Life Sciences | Ethics | Cancer
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 10/2019, Volume 51, Issue 10, pp. 1461 - 1469
Compared with the guaiac-faecal occult blood test (gFOBT), faecal immunological tests (FIT) are considered to be more effective for colorectal cancer (CRC)... 
Immunochemical faecal occult blood test | Colonoscopy | Colorectal cancer | Colorectal cancer screening | Guaiac faecal occult blood test | Adenoma | Advanced adenoma | QUALITY | PROGRAMS | PERFORMANCE | GASTROENTEROLOGY & HEPATOLOGY | Medical examination | Oncology, Experimental | Diagnosis | Research | Blood | Cancer | Life Sciences
Journal Article
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 09/2018, Volume 50, Issue 9, pp. 974 - 975
We thank Dr. Barel et al. for their letter concerning our article [1]. In this letter, the authors reported their experience of 1264 RAS tests performed... 
GASTROENTEROLOGY & HEPATOLOGY | TISSUE | Life Sciences | Human health and pathology | Genetics | Hépatology and Gastroenterology | Human genetics | Cancer
Journal Article
Clinical Nuclear Medicine, ISSN 0363-9762, 11/2015, Volume 40, Issue 11, pp. e516 - e517
ABSTRACTPrimary renal neuroendocrine tumors (NETs) are low-grade tumors with neuroendocrine differentiation and have been reported to arise most commonly in... 
Multimodal Imaging | Somatostatin - analogs & derivatives | Humans | Middle Aged | Neuroendocrine Tumors - diagnostic imaging | Dihydroxyphenylalanine - analogs & derivatives | Female | Tomography, X-Ray Computed | Positron-Emission Tomography | Radiopharmaceuticals | Fused Kidney - diagnostic imaging
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 2017, Volume 49, Issue 6, pp. 692 - 696
Journal Article